8-K

Company

Carisma Therapeutics Inc.

Filed

April 5, 2021

Period of Report

April 5, 2021

Accession Number

0001485003-21-000075

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →